Loading…

Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study

The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) wo...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 2020-04, Vol.39 (4), p.717-721
Main Authors: Alicja, Ekiel, Małgorzata, Romanik, Małgorzata, Aptekorz, Elżbieta, Semik-Grabarczyk, Paweł, Cieślik, Dominika, Smolec, Jarosław, Jóźwiak, Michał, Holecki, Gayane, Martirosian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343
cites cdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343
container_end_page 721
container_issue 4
container_start_page 717
container_title European journal of clinical microbiology & infectious diseases
container_volume 39
creator Alicja, Ekiel
Małgorzata, Romanik
Małgorzata, Aptekorz
Elżbieta, Semik-Grabarczyk
Paweł, Cieślik
Dominika, Smolec
Jarosław, Jóźwiak
Michał, Holecki
Gayane, Martirosian
description The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups, U. parvum occurred significantly more frequently. M. genitalium was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs. Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.
doi_str_mv 10.1007/s10096-019-03783-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2336999692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2336999692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</originalsourceid><addsrcrecordid>eNp9kUFP3DAQha2qqCy0f4BDZakXOARsj7OOe6sQBaSVWqnt2XKcCRsUx6mddJV_X9MFKnHgMpbl770ZzyPkhLNzzpi6SLnqdcG4LhioCordG7LiEspCgoK3ZMU0yEIrAYfkKKV7lkWVUu_IIfAKRMXUimy_R_xjexwc0tDSOYY7HLrJ9tQvLoy9Td4m2g10Fzzm2k1bmpY0oe8c7edxThTjMm3R2ymkfDv9sbk6-0zHiH3nu8HGhaZpbpb35KC1fcIPj-cx-fX16uflTbH5dn17-WVTOFDlVEihObSWNXlEga1swCmnQNaMubIRCrGubWtbXmpXoZLIhKjdupWW1RxBwjE53fuOMfyeMU3Gd8lh39sBw5yMAFhrrddaZPTTC_Q-zHHI02VK5d1VlS4zJfaUiyGliK0ZY-fzvwxn5iEHs8_B5BzMvxzMLos-PlrPtcfmWfK0-AzAHkj5abjD-L_3K7Z_AXb2lYM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2379348895</pqid></control><display><type>article</type><title>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</title><source>Springer Nature</source><creator>Alicja, Ekiel ; Małgorzata, Romanik ; Małgorzata, Aptekorz ; Elżbieta, Semik-Grabarczyk ; Paweł, Cieślik ; Dominika, Smolec ; Jarosław, Jóźwiak ; Michał, Holecki ; Gayane, Martirosian</creator><creatorcontrib>Alicja, Ekiel ; Małgorzata, Romanik ; Małgorzata, Aptekorz ; Elżbieta, Semik-Grabarczyk ; Paweł, Cieślik ; Dominika, Smolec ; Jarosław, Jóźwiak ; Michał, Holecki ; Gayane, Martirosian</creatorcontrib><description>The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups, U. parvum occurred significantly more frequently. M. genitalium was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs. Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-019-03783-w</identifier><identifier>PMID: 31832807</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Autoimmune diseases ; Biomedical and Life Sciences ; Biomedicine ; Chronic conditions ; Etiology ; Internal Medicine ; Lupus ; Medical Microbiology ; Original Article ; Systemic lupus erythematosus</subject><ispartof>European journal of clinical microbiology &amp; infectious diseases, 2020-04, Vol.39 (4), p.717-721</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>European Journal of Clinical Microbiology and Infectious Diseases is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</citedby><cites>FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</cites><orcidid>0000-0002-4603-9758 ; 0000-0002-3289-1050 ; 0000-0002-7343-4702 ; 0000-0002-0311-0884 ; 0000-0001-8601-1752 ; 0000-0002-3723-3591 ; 0000-0002-2998-6542 ; 0000-0003-0377-9833 ; 0000-0002-7871-528X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31832807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alicja, Ekiel</creatorcontrib><creatorcontrib>Małgorzata, Romanik</creatorcontrib><creatorcontrib>Małgorzata, Aptekorz</creatorcontrib><creatorcontrib>Elżbieta, Semik-Grabarczyk</creatorcontrib><creatorcontrib>Paweł, Cieślik</creatorcontrib><creatorcontrib>Dominika, Smolec</creatorcontrib><creatorcontrib>Jarosław, Jóźwiak</creatorcontrib><creatorcontrib>Michał, Holecki</creatorcontrib><creatorcontrib>Gayane, Martirosian</creatorcontrib><title>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</title><title>European journal of clinical microbiology &amp; infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups, U. parvum occurred significantly more frequently. M. genitalium was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs. Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.</description><subject>Autoimmune diseases</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Chronic conditions</subject><subject>Etiology</subject><subject>Internal Medicine</subject><subject>Lupus</subject><subject>Medical Microbiology</subject><subject>Original Article</subject><subject>Systemic lupus erythematosus</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kUFP3DAQha2qqCy0f4BDZakXOARsj7OOe6sQBaSVWqnt2XKcCRsUx6mddJV_X9MFKnHgMpbl770ZzyPkhLNzzpi6SLnqdcG4LhioCordG7LiEspCgoK3ZMU0yEIrAYfkKKV7lkWVUu_IIfAKRMXUimy_R_xjexwc0tDSOYY7HLrJ9tQvLoy9Td4m2g10Fzzm2k1bmpY0oe8c7edxThTjMm3R2ymkfDv9sbk6-0zHiH3nu8HGhaZpbpb35KC1fcIPj-cx-fX16uflTbH5dn17-WVTOFDlVEihObSWNXlEga1swCmnQNaMubIRCrGubWtbXmpXoZLIhKjdupWW1RxBwjE53fuOMfyeMU3Gd8lh39sBw5yMAFhrrddaZPTTC_Q-zHHI02VK5d1VlS4zJfaUiyGliK0ZY-fzvwxn5iEHs8_B5BzMvxzMLos-PlrPtcfmWfK0-AzAHkj5abjD-L_3K7Z_AXb2lYM</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Alicja, Ekiel</creator><creator>Małgorzata, Romanik</creator><creator>Małgorzata, Aptekorz</creator><creator>Elżbieta, Semik-Grabarczyk</creator><creator>Paweł, Cieślik</creator><creator>Dominika, Smolec</creator><creator>Jarosław, Jóźwiak</creator><creator>Michał, Holecki</creator><creator>Gayane, Martirosian</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4603-9758</orcidid><orcidid>https://orcid.org/0000-0002-3289-1050</orcidid><orcidid>https://orcid.org/0000-0002-7343-4702</orcidid><orcidid>https://orcid.org/0000-0002-0311-0884</orcidid><orcidid>https://orcid.org/0000-0001-8601-1752</orcidid><orcidid>https://orcid.org/0000-0002-3723-3591</orcidid><orcidid>https://orcid.org/0000-0002-2998-6542</orcidid><orcidid>https://orcid.org/0000-0003-0377-9833</orcidid><orcidid>https://orcid.org/0000-0002-7871-528X</orcidid></search><sort><creationdate>20200401</creationdate><title>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</title><author>Alicja, Ekiel ; Małgorzata, Romanik ; Małgorzata, Aptekorz ; Elżbieta, Semik-Grabarczyk ; Paweł, Cieślik ; Dominika, Smolec ; Jarosław, Jóźwiak ; Michał, Holecki ; Gayane, Martirosian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Autoimmune diseases</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Chronic conditions</topic><topic>Etiology</topic><topic>Internal Medicine</topic><topic>Lupus</topic><topic>Medical Microbiology</topic><topic>Original Article</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alicja, Ekiel</creatorcontrib><creatorcontrib>Małgorzata, Romanik</creatorcontrib><creatorcontrib>Małgorzata, Aptekorz</creatorcontrib><creatorcontrib>Elżbieta, Semik-Grabarczyk</creatorcontrib><creatorcontrib>Paweł, Cieślik</creatorcontrib><creatorcontrib>Dominika, Smolec</creatorcontrib><creatorcontrib>Jarosław, Jóźwiak</creatorcontrib><creatorcontrib>Michał, Holecki</creatorcontrib><creatorcontrib>Gayane, Martirosian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alicja, Ekiel</au><au>Małgorzata, Romanik</au><au>Małgorzata, Aptekorz</au><au>Elżbieta, Semik-Grabarczyk</au><au>Paweł, Cieślik</au><au>Dominika, Smolec</au><au>Jarosław, Jóźwiak</au><au>Michał, Holecki</au><au>Gayane, Martirosian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study</atitle><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>39</volume><issue>4</issue><spage>717</spage><epage>721</epage><pages>717-721</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups, U. parvum occurred significantly more frequently. M. genitalium was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs. Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31832807</pmid><doi>10.1007/s10096-019-03783-w</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-4603-9758</orcidid><orcidid>https://orcid.org/0000-0002-3289-1050</orcidid><orcidid>https://orcid.org/0000-0002-7343-4702</orcidid><orcidid>https://orcid.org/0000-0002-0311-0884</orcidid><orcidid>https://orcid.org/0000-0001-8601-1752</orcidid><orcidid>https://orcid.org/0000-0002-3723-3591</orcidid><orcidid>https://orcid.org/0000-0002-2998-6542</orcidid><orcidid>https://orcid.org/0000-0003-0377-9833</orcidid><orcidid>https://orcid.org/0000-0002-7871-528X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0934-9723
ispartof European journal of clinical microbiology & infectious diseases, 2020-04, Vol.39 (4), p.717-721
issn 0934-9723
1435-4373
language eng
recordid cdi_proquest_miscellaneous_2336999692
source Springer Nature
subjects Autoimmune diseases
Biomedical and Life Sciences
Biomedicine
Chronic conditions
Etiology
Internal Medicine
Lupus
Medical Microbiology
Original Article
Systemic lupus erythematosus
title Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A04%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20urogenital%20mycoplasmas%20in%20women%20with%20systemic%20lupus%20erythematosus%20(SLE):%20preliminary%20study&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Alicja,%20Ekiel&rft.date=2020-04-01&rft.volume=39&rft.issue=4&rft.spage=717&rft.epage=721&rft.pages=717-721&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-019-03783-w&rft_dat=%3Cproquest_cross%3E2336999692%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-42913fa0d3182ef4d3c7c734b00c5d27eebbafaf159c8e74e022bc6f4a0b1e343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2379348895&rft_id=info:pmid/31832807&rfr_iscdi=true